Navigation Links
St. Joseph's Hospital, University of Arizona Create Valley Fever Center in Phoenix
Date:10/4/2011

itute," said Dr. Galgiani.  "Having the UA College of Medicine now in Phoenix can build on these resources and increase the opportunities for medical education and biomedical research to connect with the clinical activities."

Dr. Galgiani also noted that many doctors in Phoenix already have a lot of experience with diagnosing and treating the disease.

"The problem is that patients with Valley Fever often cannot find the right doctor or they have such complicated problems that they can't get all of the needed expertise coordinated," Dr. Galgiani said. "The new center is planned to integrate the skills of many specialists resulting in better care for patients and better support for physicians through coordination and consultation."


'/>"/>
SOURCE St. Joseph's Hospital and Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Waters Honors University of Minnesotas Joseph Dalluge, Ph.D. and Department of Chemistry Mass Spectrometry Laboratory with Center of Innovation Recognition
2. Rice University lab develops technique to control light from nanoparticles
3. Parent Project Muscular Dystrophy Awards End Duchenne Grant to University of Pennsylvanias Dr. Tejvir S. Khurana
4. University of Western Ontario researchers investigate stress and breast cancer
5. SanBio Announces Site Opening of Phase 1/2a Clinical Trial of Novel Cell Therapy in Stable Stroke Patients at University of Pittsburgh Medical Center
6. HUYA Bioscience International Forms Alliance With Zhejiang Chinese Medical University Life Science College
7. Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation
8. University of Houston receives NSF grant for high school teachers program
9. New nanoscale parameter by Aalto University resolves dilemmas on silicon property
10. University of Muenster Bridges 1st Patient to Transplant with SynCardias Total Artificial Heart
11. Elsevier and the National University of Singapore Announce Winners of 24-Hour Hackathon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... Rainbow Scientific, Inc. (RSI), a North American ... BI’s line of human mesenchymal stem cell (hMSC) differentiation media, MSC go ... complete system for multipotency evaluation of hMSCs and reliable induction of hMSCs into ...
(Date:7/28/2015)... July 29, 2015 A ... acquiring, rapidly developing and commercialising innovative medicines to ... Highly experienced management team; blue chip ...   Mereo BioPharma Group Ltd ("Mereo"), a recently-formed ... ( c. £76.5m), gross, from blue chip institutional investors ...
(Date:7/28/2015)... , July 28, 2015  PDL BioPharma, Inc. ... announced that the Company will release its second quarter ... 2015, on Wednesday, August 5, 2015, after market close. ... that day at 4:30 p.m. Eastern Time to discuss ... call will be available via the webcast link on ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... than EUR 1.022 billion in 2013; while production volume reached close to 1.84 ... producing country with a share of 75.5% of the region’s total aluminium hydroxide ...
Breaking Biology Technology:Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3
... Advice Shared Through Dynamic WikiAnswers Q&A ... ... a show of support for National,Breast Cancer Awareness Month, Answers.com,s question ... ), where breast cancer survivors,friends and family have gathered to ask ...
... Win Needed Medical ... Oct. 22 Television medical dramas such as,ER and House ... country to millions of Americans each week. Now, small hospitals,lacking ... - are being given the opportunity to turn the cameras ...
... 22 Genzyme Corp.,(Nasdaq: GENZ ) today ... granted marketing approval for Renvela(TM) (sevelamer carbonate) for,the ... kidney disease on,dialysis. Renvela is a next-generation version ... the United States. "Since its approval in ...
Cached Biology Technology:Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 2Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 3American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 2American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 3FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 2FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 3FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 4FDA Approves Genzyme's Renvela(TM) for Dialysis Patients 5
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
(Date:6/25/2015)... CITY , June 25, 2015  Imagine a ... steps toward a healthier, happier life. That,s exactly what ... designed to do. The cutting-edge, portable health program provides ... real-life solutions to help improve your lifestyle and nutrition. ... awards dinner and gala Wednesday night, USANA,s THA was ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... cells communicate with each other and how to enhance ... promising work by a Kansas State University researcher. ... of diagnostic medicine and pathobiology at K-State,s College of ... National Institutes of Health to continue her cancer research. ...
... postmenopausal hormone therapy for more than 15 years increases ... leaner women according to research at the Keck School ... An analysis of the California Teachers Study focused ... women for nearly 10 years. The research was conducted ...
... Georgia Institute of Technology have attained very promising results on ... Using a new technique involving mass spectrometry of a single ... ovarian cancer in 100 percent of the patients tested. The ... Epidemiology, Biomarkers, & Prevention Research . "Because ovarian ...
Cached Biology News:K-State professor's cancer research gets boost from National Institutes of Health 2K-State professor's cancer research gets boost from National Institutes of Health 3Cancer risk found for long-term hormone therapy 2Initial trials on new ovarian cancer tests exhibit extremely high accuracy 2
... ReadyPrep 2-D starter kit is intended for first-time ... IPG strips. The kit includes a protein sample ... to second-dimension gels six 17 cm, ten 11 ... (ReadyStrip IPG strips and precast SDS-PAGE gels and ...
... Phosphate Phosphatase 2 (LPP2) ... aqueous solution Solution ... containing 0.08% sodium azide. ... the human LPP2 protein. ...
... Phospho-Specific(Thr 222 ) ... 10 mM sodium HEPES, 100 ... 7.5. Recognizes the ~47 kDa ... (MAPKAPK-2) protein phosphorylated at Thr ...
Rabbit polyclonal to SMURF 2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide (10-30 aa in length) at the N-term of first 50 aa of human SMURF 2. Entrez G...
Biology Products: